Citadel Advisors
BHC icon

Citadel Advisors’s Bausch Health BHC Stock Holding History

Citadel Advisors’s Portfolio BHC Stock Details BHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.93M Sell
912,171
-575,124
-39% -$3.44M ﹤0.01% 4363
2025
Q4 		$10.3M Buy
1,487,295
+1,459,715
+5,293% +$9.6M ﹤0.01% 3214
2025
Q3 		$178K Buy
27,580
+5,760
+26% +$39.4K ﹤0.01% 11382
2025
Q2 		$145K Sell
21,820
-1,236,516
-98% -$6.35M ﹤0.01% 10986
2025
Q1 		$8.14M Sell
1,258,336
-3,942,460
-76% -$28.3M ﹤0.01% 3136
2024
Q4 		$41.9M Buy
5,200,796
+55,804
+1% +$460K 0.01% 1437
2024
Q3 		$42M Sell
5,144,992
-1,932,314
-27% -$12.7M 0.01% 1379
2024
Q2 		$49.3M Buy
7,077,306
+3,225,724
+84% +$24.4M 0.01% 1160
2024
Q1 		$40.9M Sell
3,851,582
-2,987,389
-44% -$26.1M 0.01% 1390
2023
Q4 		$54.8M Buy
6,838,971
+716,815
+12% +$5.22M 0.01% 1104
2023
Q3 		$50.3M Buy
6,122,156
+3,955,893
+183% +$34.1M 0.01% 1072
2023
Q2 		$17.3M Buy
2,166,263
+1,666,151
+333% +$12.3M ﹤0.01% 2036
2023
Q1 		$4.05M Sell
500,112
-759,039
-60% -$6.09M ﹤0.01% 4139
2022
Q4 		$7.91M Sell
1,259,151
-670,719
-35% -$4.68M ﹤0.01% 3155
2022
Q3 		$13.3M Buy
1,929,870
+257,334
+15% +$1.79M ﹤0.01% 2373
2022
Q2 		$14M Buy
1,672,536
+517,280
+45% +$7.23M ﹤0.01% 2262
2022
Q1 		$26.4M Sell
1,155,256
-271,567
-19% -$6.64M 0.01% 1687
2021
Q4 		$39.4M Buy
1,426,823
+119,786
+9% +$3.21M 0.01% 1365
2021
Q3 		$36.4M Sell
1,307,037
-451,150
-26% -$12.8M 0.01% 1377
2021
Q2 		$51.5M Buy
1,758,187
+542,224
+45% +$16.4M 0.01% 1098
2021
Q1 		$38.6M Sell
1,215,963
-994,684
-45% -$29.2M 0.01% 1267
2020
Q4 		$46M Sell
2,210,647
-265,733
-11% -$4.96M 0.01% 1013
2020
Q3 		$38.5M Buy
2,476,380
+2,127,333
+609% +$36.6M 0.01% 1035
2020
Q2 		$6.38M Sell
349,047
-332,621
-49% -$5.86M ﹤0.01% 2747
2020
Q1 		$10.6M Buy
681,668
+79,628
+13% +$1.92M ﹤0.01% 1787
2019
Q4 		$18M Sell
602,040
-525,981
-47% -$13.7M 0.01% 1579
2019
Q3 		$24.6M Buy
1,128,021
+425,135
+60% +$9.73M 0.01% 1290
2019
Q2 		$17.7M Sell
702,886
-1,191
-0.2% -$28.3K 0.01% 1538
2019
Q1 		$17.4M Sell
704,077
-1,964,183
-74% -$46.9M 0.01% 1466
2018
Q4 		$49.3M Buy
2,668,260
+1,494,492
+127% +$35.5M 0.03% 626
2018
Q3 		$30.1M Sell
1,173,768
-56,779
-5% -$1.3M 0.01% 1083
2018
Q2 		$28.6M Sell
1,230,547
-144,335
-10% -$2.98M 0.01% 1033
2018
Q1 		$21.9M Buy
1,374,882
+986,386
+254% +$18.4M 0.01% 1054
2017
Q4 		$8.07M Sell
388,496
-1,243,228
-76% -$19.7M ﹤0.01% 1942
2017
Q3 		$23.4M Buy
1,631,724
+1,178,006
+260% +$17.8M 0.02% 972
2017
Q2 		$7.85M Sell
453,718
-1,013,208
-69% -$12.1M 0.01% 1655
2017
Q1 		$16.2M Sell
1,466,926
-307,556
-17% -$4.23M 0.01% 1103
2016
Q4 		$25.8M Sell
1,774,482
-1,581,548
-47% -$29M 0.03% 702
2016
Q3 		$82.4M Buy
3,356,030
+1,923,768
+134% +$49.8M 0.08% 211
2016
Q2 		$28.8M Buy
1,432,262
+537,768
+60% +$15.2M 0.03% 574
2016
Q1 		$23.5M Buy
894,494
+56,325
+7% +$4.17M 0.03% 664
2015
Q4 		$85.2M Buy
838,169
+530,282
+172% +$59.6M 0.09% 225
2015
Q3 		$54.9M Sell
307,887
-122,878
-29% -$28.7M 0.05% 395
2015
Q2 		$95.7M Buy
430,765
+272,342
+172% +$60.4M 0.08% 249
2015
Q1 		$31.5M Sell
158,423
-837,020
-84% -$148M 0.03% 721
2014
Q4 		$142M Buy
995,443
+820,366
+469% +$110M 0.14% 110
2014
Q3 		$23M Buy
175,077
+154,170
+737% +$18.4M 0.02% 831
2014
Q2 		$2.64M Sell
20,907
-605,415
-97% -$77.2M ﹤0.01% 2464
2014
Q1 		$82.6M Buy
626,322
+208,711
+50% +$28.5M 0.1% 214
2013
Q4 		$49M Buy
417,611
+255,103
+157% +$28M 0.06% 364
2013
Q3 		$17M Sell
162,508
-118,861
-42% -$11.6M 0.03% 800
2013
Q2 		$24.2M Buy
+281,369
New +$22.2M 0.04% 553

Other funds holding BHC

PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
MP
MFN Partners Boston, Massachusetts $4.77B AUM 72.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citadel Advisors's BHC Position: Q1 2026 in Review

Citadel Advisors reduced its Bausch Health (BHC) stake by 39% in Q1 2026, selling an estimated $3.44M and leaving 912,171 shares worth $4.93M. The position accounts for ﹤0.01% of the portfolio, ranked #4363.

Citadel Advisors first reported a position in BHC in Q2 2013 and has held it in 52 quarters since. The position peaked at $142M in Q4 2014. 227 funds tracked by Wall St. Rank hold BHC as of Q1 2026.

  • Citadel Advisors held 912,171 shares of Bausch Health worth $4.93M as of Q1 2026.
  • Citadel Advisors sold 575,124 Bausch Health shares in Q1 2026, an estimated $3.44M.
  • Bausch Health made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #4363 holding.
  • Citadel Advisors first reported a position in Bausch Health in Q2 2013 and has held it in 52 quarters since.
  • Citadel Advisors's Bausch Health position peaked at $142M in Q4 2014.
  • 227 funds tracked by Wall St. Rank held Bausch Health as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.